ARCHIVES

Cooperative Group chairmen Cool, But High Priority Trials To Continue

This article is from The Cancer Letter archive.

Vol. 17 No. 03 | January 18, 1991

Download PDF Visit The Full Archive

Related Articles

NIH Seeking Nominations for Review Committees

February 23, 1979

NCI Would Add Money For Centers If Number Go Up, Greenwald Says; Five Options For Changes Listed

April 27, 1984

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

Underpowered Study Of Evacet Dashes Approval Hopes

September 24, 1999

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980